These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9236953)

  • 81. The 'Severe Impairment Battery': assessing cognitive ability in adults with Down syndrome.
    Witts P; Elders S
    Br J Clin Psychol; 1998 May; 37(2):213-6. PubMed ID: 9631208
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Reliability of clinical nurse specialists in the staging of dementia.
    McCulla MM; Coats M; Van Fleet N; Duchek J; Grant E; Morris JC
    Arch Neurol; 1989 Nov; 46(11):1210-1. PubMed ID: 2818255
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Global change assessments in anti-Alzheimer clinical drug trials.
    Knopman DS
    Dement Geriatr Cogn Disord; 1998; 9 Suppl 3():8-15. PubMed ID: 9853197
    [TBL] [Abstract][Full Text] [Related]  

  • 84. The GDS/FAST staging system.
    Auer S; Reisberg B
    Int Psychogeriatr; 1997; 9 Suppl 1():167-71. PubMed ID: 9447440
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Review of Alzheimer's disease scales: is there a need for a new multi-domain scale for therapy evaluation in medical practice?
    Robert P; Ferris S; Gauthier S; Ihl R; Winblad B; Tennigkeit F
    Alzheimers Res Ther; 2010 Aug; 2(4):24. PubMed ID: 20796301
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Performance-based and Observational Assessments in Clinical Trials Across the Alzheimer's Disease Spectrum.
    Harvey PD; Cosentino S; Curiel R; Goldberg TE; Kaye J; Loewenstein D; Marson D; Salmon D; Wesnes K; Posner H
    Innov Clin Neurosci; 2017; 14(1-2):30-39. PubMed ID: 28386519
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Policy Implications for Pain in Advanced Alzheimer's Disease.
    Anderson AR; Hyden K; Failla MD; Carter MA
    Pain Manag Nurs; 2021 Feb; 22(1):3-7. PubMed ID: 32684495
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Targeting
    Carles A; Freyssin A; Perin-Dureau F; Rubinstenn G; Maurice T
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612544
    [No Abstract]   [Full Text] [Related]  

  • 89. Effects of GV1001 on Language Dysfunction in Patients With Moderate-to-Severe Alzheimer's Disease:
    Kwon HS; Koh SH; Choi SH; Jeong JH; Na HR; Lee CN; Yang Y; Lee AY; Lee JH; Park KW; Han HJ; Kim BC; Park J; Lee JY; Lee KY; Kim S
    Dement Neurocogn Disord; 2023 Jul; 22(3):100-108. PubMed ID: 37545861
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Evaluating the treatment outcomes of repetitive transcranial magnetic stimulation in patients with moderate-to-severe Alzheimer's disease.
    Zhang S; Liu L; Zhang L; Ma L; Wu H; He X; Cao M; Li R
    Front Aging Neurosci; 2022; 14():1070535. PubMed ID: 36688172
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Clinical Trial Endpoints and Their Clinical Meaningfulness in Early Stages of Alzheimer's Disease.
    Cohen S; Cummings J; Knox S; Potashman M; Harrison J
    J Prev Alzheimers Dis; 2022; 9(3):507-522. PubMed ID: 35841252
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Non-benzodiazepine hypnotic use for sleep disturbance in people aged over 55 years living with dementia: a series of cohort studies.
    Richardson K; Savva GM; Boyd PJ; Aldus C; Maidment I; Pakpahan E; Loke YK; Arthur A; Steel N; Ballard C; Howard R; Fox C
    Health Technol Assess; 2021 Jan; 25(1):1-202. PubMed ID: 33410736
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Linking the Mini-Mental State Examination, the Alzheimer's Disease Assessment Scale-Cognitive Subscale and the Severe Impairment Battery: evidence from individual participant data from five randomised clinical trials of donepezil.
    Levine SZ; Yoshida K; Goldberg Y; Samara M; Cipriani A; Efthimiou O; Iwatsubo T; Leucht S; Furukawa TA
    Evid Based Ment Health; 2021 May; 24(2):56-61. PubMed ID: 33023920
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Reliability and validity of the severe impairment battery in Taiwanese patients with moderate to severe Alzheimer's disease.
    Huang MH; Tsai CF; Hu CJ; Lin YT; Yang YH; Wang WF; Lee WJ; Fuh JL
    J Chin Med Assoc; 2020 Nov; 83(11):1014-1019. PubMed ID: 32796320
    [TBL] [Abstract][Full Text] [Related]  

  • 95. The "rights" of precision drug development for Alzheimer's disease.
    Cummings J; Feldman HH; Scheltens P
    Alzheimers Res Ther; 2019 Aug; 11(1):76. PubMed ID: 31470905
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Variability in the validity and reliability of outcome measures identified in a systematic review to assess treatment efficacy of cognitive enhancers for Alzheimer's Dementia.
    Soobiah C; Tadrous M; Knowles S; Blondal E; Ashoor HM; Ghassemi M; Khan PA; Ho J; Tricco AC; Straus SE
    PLoS One; 2019; 14(4):e0215225. PubMed ID: 30998774
    [TBL] [Abstract][Full Text] [Related]  

  • 97. The effect of dietary supplementation on brain-derived neurotrophic factor and cognitive functioning in Alzheimer's dementia.
    Martin A; Stillman J; Miguez MJ; McDaniel HR; Konefal J; Woolger JM; Lewis JE
    J Clin Transl Res; 2018 Jan; 3(3):337-343. PubMed ID: 30895275
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Memantine for dementia.
    McShane R; Westby MJ; Roberts E; Minakaran N; Schneider L; Farrimond LE; Maayan N; Ware J; Debarros J
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD003154. PubMed ID: 30891742
    [TBL] [Abstract][Full Text] [Related]  

  • 99. A Randomized, Double-Blind, Placebo-Controlled, Phase II Study Assessing Safety, Tolerability, and Efficacy of Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's Disease.
    Farlow MR; Thompson RE; Wei LJ; Tuchman AJ; Grenier E; Crockford D; Wilke S; Benison J; Alkon DL
    J Alzheimers Dis; 2019; 67(2):555-570. PubMed ID: 30530975
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Validation of the English Version of the Multimodal Assessment of Capacities in Severe Dementia (MAC-SD): A Cognitive and Functional Scale for Use in Severe Dementia.
    Heller S; Steinberg A; Sedler M
    J Alzheimers Dis Rep; 2017 Dec; 1(1):249-262. PubMed ID: 30480242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.